Lori Gough

Lori Gough is a seasoned professional in the biotech and pharmaceutical sectors with over 20 years of experience. Currently a Partner at Epidarex Capital since August 2023, Gough focuses on early-stage investments in life sciences and health technology. Previous roles include Chief Business and Strategy Officer at NeuExcell Therapeutics Inc., and Vice President of Corporate Development at Tmunity Therapeutics, where efforts were directed towards advancing T cell immunotherapy. Earlier career highlights encompass senior positions at GSK, where Gough contributed to platform technology business development and academic partnerships, and positions at Pfizer involving significant research leadership. Gough holds a PhD in Organic Chemistry from the University of Pennsylvania and a BS in Organic Chemistry from Colgate University.